TUMORS OF CENTRAL NERVOUS
SYSTEM
Dr. VKS Gautam
It is very important to use authentic
terms for the cns tumors and have an overall view about all the tumors of the
central nervous system. Various nomenclatures and classifications are used for description. Therefore, it is imperative to know what is most authentic
and easiest way to remember. The pathological classification of cns tumors is
the most common and most practical way of nomenclature and classification of
such tumors.
CNS tumors, especially gliomas,
contrary to the other cancers of the body , cannot be classified like Benign or
Malignant or Cancer and Non cancer or like Benign lesion of the Breast (
Fibroadenoma) and Cancer of the breast ( Ca Breast) , or Benign Prostrate
Hyperplasia (BPH) and Cancer of the Prostrate. On the contrary, the Gliomas or
Astrocytomas are classified on the basis of features of neoplasia- like
cellular atypia, nuclear proliferation, vascular proliferation & necrosis. So, there is a grading
of neoplasia. Cushing and Bailey classification was an earlier effort to
classify brain tumors. World Health
Organization ( WHO) classification of tumors
of central nervous system is a comprehensive,
authentic and up to date source of reference. I have made an effort to
create an outline and curtail the details so that any doctor can have an
overview of all the tumors of CNS. The details of all such tumors should be read in conjunction with the radiological
findings which is more interesting and easy.
About a century back Harvey Cushing published his work on brain tumors.
World Health Organization Classification of the Central Nervous System , fourth edition (WHO 2007), lists more than 120 types of brain tumors. This is broadly a histopathological classification.
World Health Organization Classification of the Central Nervous System , fourth edition (WHO 2007), lists more than 120 types of brain tumors. This is broadly a histopathological classification.
How to understand about brain tumors? We are very much familier with the nomenclature used in the older classifications . A comprehensive WHO classification of CNS tumors helps in understanding the characterstics of the brain tumors . So, while describing these tumors, for a better understanding, older terms in conjuction with newer terms should be used.
GLIOMA is the commonest primary brain tumor. Glioma arises from glial cells. Since glial cells are far more in number than neuronal cells, it will be easy to understand the fact that gliomas are more common. Glial cells comprise of astrocytes, oligodendrocytes, ependymal cells so the gliomas can further be subclassified as astrocytoma ( commonest type of glioma ), oligodendroglioma and ependymoma. According to WHO classification, these tumors can further be subclassified on the basis of features of malignancy ( microvascular proliferation, cellular atypia, mitotic activity , necrosis ) from grade I, II, III and IV.
AS neuronal cells are less in number than glial cells it is easy to remember that tumors like NEURONAL & MIXED NEURONAL GLIAL TUMORS are less common , and relatively benign tumors . Gangliocytoma ( WHO grade I ) and ganglioglioma ( WHO grade I or III ) are well differentiated tumors composed of neoplastc mature appearing neurons alone ( gangliocytoma) or neoplastic ganglion cells combined with glioma cells ( ganglioglioma). Dysplastc gangliocytoma of the cerebellum ( Lhermitte-Duclos disease, WHO grade I ) is associated with Cowden syndrome in 50 % cases. Central Neurocytoma & extraventricular neurocytoma ( WHO grade II ) are low grade neoplasms of young adults. Paraganglioma of the filum terminale ( WHO grade I ), Papillary glioneuronal tumor ( WHO grade I ) are surgically curable tumors. Dysembryoplastic neuroepithelial tumors ( DNT; WHO grade I ) is a low grade quasihamartomatous tumor that occurs in childrenand young patients with history of long standing resistant seizures.
Summary of the WHO Classification of CNS Tumors ( 2007) for comprehensive but easy to recapitulate the overview of CNS tumors
Summary of the WHO Classification of CNS Tumors ( 2007) for comprehensive but easy to recapitulate the overview of CNS tumors
1. Tumours of neuroepithelial tissue
1.1.
Astrocytic tumours
Pilocytic astrocytoma &
Subependymal giant cell astrocytoma (WHO grade I)
Pilomyxoid astrocytoma & Pleomorphic
xanthoastrocytoma (WHO grade II)
Diffuse astrocytoma (WHO grade II)
Variants: protoplasmic, gemistocytic, fibrillary,
mixed
Anaplastic
astrocytoma (WHO grade III)
Glioblastoma (WHO grade IV)
a.
Giant cell glioblastoma
b.
Gliosarcoma
Gliomatosis cerebri (WHO grade III)
1.2.
Oligodendroglial tumours
Oligodendroglioma (WHO grade
II)
Anaplastic oligodendroglioma
(WHO grade III)
1.3.
Oligoastrocytic tumours
Oligoastrocytoma
(WHO grade II)
Anaplastic oligoastrocytoma (WHO grade III)
1.4.
Ependymal tumours
Subependymoma & Myxopapillary ependymoma (WHO grade I)
Ependymoma (WHO grade II)
Anaplastic ependymoma (WHO grade
III)
1.5. Choroid
plexus tumours
Choroid plexus papilloma (WHO grade I)
Atypical choroid plexus
papilloma ( WHO grade II)
Choroid plexus carcinoma (WHO grade III)
1.6. Other
neuroepithelial tumours
Astroblastoma (WHO grade I)
Chordoid glioma of the third
ventricle (WHO grade II)
Angiocentric glioma (WHO
grade I)
1.7.
Neuronal and mixed neuronal-glial tumours
Dysplastic gangliocytoma of
cerebellum (Lhermitte-Duclos),
Desmoplastic infantile
astrocytoma/ganglioglioma,
Dysembryoplastic
neuroepithelial tumour,
Gangliocytoma ,
Ganglioglioma
Papillary glioneuronal
tumour
Rosette-forming
glioneuronal tumour of the fourth ventricle, &
Paraganglioma are WHO grade
I tumors.
Central neurocytoma &
Extraventricular neurocytoma , Cerebellar liponeurocytoma (WHO grade II)
Anaplastic ganglioglioma (WHO grade III)
1.8. Tumours
of the pineal region
Pineocytoma (WHO grade I)
Pineal parenchymal tumour of
intermediate differentiation (WHO grade II, III)
Pineoblastoma (WHO grade IV)
Papillary tumors of the pineal
region (WHO grade II, III)
1.9.
Embryonal tumours
Medulloblastoma (WHO grade IV)
Medulloblastoma with extensive
nodularity (WHO grade IV)
Anaplastic medulloblastoma (WHO
grade IV)
CNS Primitive neuroectodermal
tumour (WHO grade IV)
CNS Neuroblastoma (WHO grade IV)
Atypical teratoid/rhabdoid tumour
(WHO grade IV)
2. Tumours of cranial and paraspinal nerves
Schwannoma (WHO grade I)
Neurofibroma (WHO grade I)
Perineurioma (WHO grade I, II,
III)
Malignant peripheral nerve sheath
tumour (MPNST) (WHO grade II, III, IV)
3. Tumours of the meninges
3.1 Tumours
of meningothelial cells
Meningioma
Variants ( Subtypes ): meningothelial, fibrous (fibroblastic), transitional (mixed), psammomatous, angiomatous, microcystic, secretory, clear cell, chordoid, lymphoplasmacyte-rich, and metaplastic
Atypical meningioma (WHO grade II)
Anaplastic meningioma (WHO grade III)
3.2
Mesenchymal tumours
Lipoma ,
Angiolipoma ,Liposarcoma, Leiomyoma,
Leiomyosarcoma, Solitary fibrous tumour , Fibrosarcoma , Rhabdomyoma, Rhabdomyosarcoma,Chondroma
, Chondrosarcoma, Osteoma,Osteosarcoma, Osteochondroma, Angiosarcoma, Kaposi
Sarcoma, Ewing Sarcoma - PNET
Malignant fibrous histiocytoma
Hibernoma
Haemangioma
Epithelioid hemangioendothelioma
Haemangiopericytoma & Anaplastic
haemangiopericytoma (WHO grade III)
3.3 Primary
melanocytic lesions
Diffuse melanocytosis
Melanocytoma
Malignant melanoma
Meningeal
melanomatosis
3.4 Other
neoplasms related to the meninges
Haemangioblastoma (WHO grade I)
4. Tumors of the haematopoietic system
Malignant
Lymphomas
Plasmocytoma
Granulocytic sarcoma
5. Germ cell tumours
Germinoma
Embryonal carcinoma
Yolk sac tumour
Choriocarcinoma
Teratoma
Mixed germ cell tumours
6. Tumours of the sellar region
Craniopharyngioma (WHO grade I)
Granular cell tumour (WHO grade I)
Pituicytoma (WHO grade I)
Spindle cell
oncocytoma of the adenohypophysis (WHO grade I)
7. Metastatic Tumours
The 2016 WHO Classification of CNS Tumors
The most recent and updated classification of CNS tumors is published by WHO in year 2016.
The new classification uses both molecular parameters and histological features, so, it is a combined genotype and phenotype classification. Previous classifications were mainly based on the microscopic histological features, immunohistochemical expressions and putative cell of origin of the tumors.
Over the past few decades there had been a better understanding of the genetic basis of tumorigenesis. The use of integrated phenotypic and genotypic parameters for the CNS tumor classification adds a level of objectivity in the diagnostic process leading to greater diagnostic accuracy as well as improved patient management and more accurate determination s of prognosis and treatment response.
So, the new classification proposed by WHO incorporates genetically defined entities and restructured the entire classification of tumors of central nervous system into the molecular era. Certain terms had been added and some old terms had been deleted into the new classification.
The nosological shift to a new classification based on both phenotype and genotype.
The most recent and updated classification of CNS tumors is 2016-WHO classification.
Sources
Review article
The World Health Organization classification of tumors of the central nervous system: a summary. David N. Louis, et al. Acta Neuropathol ( 2016) 131:803-820
The 2016 WHO Classification of CNS Tumors
The most recent and updated classification of CNS tumors is published by WHO in year 2016.
The new classification uses both molecular parameters and histological features, so, it is a combined genotype and phenotype classification. Previous classifications were mainly based on the microscopic histological features, immunohistochemical expressions and putative cell of origin of the tumors.
Over the past few decades there had been a better understanding of the genetic basis of tumorigenesis. The use of integrated phenotypic and genotypic parameters for the CNS tumor classification adds a level of objectivity in the diagnostic process leading to greater diagnostic accuracy as well as improved patient management and more accurate determination s of prognosis and treatment response.
So, the new classification proposed by WHO incorporates genetically defined entities and restructured the entire classification of tumors of central nervous system into the molecular era. Certain terms had been added and some old terms had been deleted into the new classification.
The nosological shift to a new classification based on both phenotype and genotype.
The most recent and updated classification of CNS tumors is 2016-WHO classification.
WHO (2016) Classification
of Tumors of Central Nervous System
In year 2016, for the first time, the World Health Organization
( WHO) classification of CNS tumors uses molecular parameters in addition to
histology to define many tumor entities. Major restructuring has been done in
diffuse gliomas, medulloblastomas and other embryonal tumors. It has added
newly recognized neoplasms, and has deleted some entities, variants and
patterns that are no longer have diagnostic and/or biological relevance.
Summary
of changes in new classification
- Major restructuring of diffuse gliomas, Medulloblastomas, other embryonal tumors & incorporation of genetically defined entities
- The term “primitive neuroectodermal tumor” is removed
- Incorporation of a genetically defined ependymoma variant - RELA fusion positive
- Addition ofNewly recognized entities, variants and patterns have been added:1. IDH-wildtype and IDH-mutant glioblastoma2. Diffuse midline glioma, H3 K27M–mutant3. Embryonal tumour with multilayered rosettes, C19MC-altered4. Ependymoma, RELA fusion–positive5. Diffuse leptomeningeal glioneuronal tumor6. Anaplastic PXA7. Epithelioid glioblastoma8. Glioblastoma with primitive neuronal component9. Multinodular and vacuolated pattern of ganglion cell tumorDeletion ofGliomatosis cerebriProtoplasmic and fibrillary astrocytoma variantscellular ependymoma variantPrimitive Neuroectodermal tumor
- Addition of Brain invasion as a criterion for atypical meningioma
- Restructuring of solitary fibrous tumor and hemangiopericytoma ( SFT/HPC) as one entity
- Expansion & clarification of entities included in of Nerve sheath tumors, with addition of hybrid nerve sheath tumors & separation of melanotic schwannoma from other schwanomas
- Expansion of entities included in hematopoietic/lymphoid tumors of the CNS ( lymphomas & histiocytic tumors)NEW CLASSIFICATIONDiffuse astrocyic and oligodendroglial tumors
- Diffuse astrocytoma, IDH-mutantGemistocytic astrocytoma, IDH-mutant
- Diffuse astrocytoma, IDH-wildtype
- Diffuse astrocytoma, NOS
- Anaplastic astrocytoma, IDH-mutant
- Anaplasticastrocytoma, IDH-wildtype
- Anaplastic astrocytoma, NOS
- Glioblastoma, IDH-wildtypeGiant cell glioblastomaGliosarcomaEpitheloid glioblastoma
- Glioblastoma, IDH-mutant
- Glioblastoma, NOS
- Diffuse midline glioma, H3 K27M-mutant
- Oligodendroglioma, IDH-mutant and 1p/19q-codeleted
- Oligodendroglioma, NOS
- Anaplastic Oligodendroglioma, IDH-mutant and 1p/19q-codeleted
- Anaplastic oligodendroglioma, NOS
- Oligoastrocytoma, NOS
- Anaplastic Oligoastrocytoma, NOSOther astrocytic tumor
- Pilocytic astrocytomaPilomyxoid astrocytoma
- Subependymal giant cell astrocytoma
- Pleomorphic xanthoastrocytoma
- Anaplastic pleomorphic xanthastrocytomaEpendymal tumors
- Subependymoma
- Myxopapillary ependymoma
- EpendymomaPapillary ependymomaClear cell ependymomaTanycytic ependymoma
- Ependymoma, RELA fusion-positiveAnaplastic ependymomaOther gliomas
- Choroid glioma of the third ventricle
- Angiocentric glioma
- AstroblastomaChoroid plexus tumors
- Choroid plexus papilloma
- Atypical choroid plexus papilloma
- Choroid plexus carcinomaNeuronal & mixed Neuronal-glial tumors
- Dysembryoplastic neuroepithelial tumor
- Gangliocytoma
- Ganglioglioma
- Anaplastic ganglioglioma
- Dysplastic cerebellar gangliocytoma ( Lhermitte-Duclos disease)
- Desmoplastic infantile astrocytoma and ganglioglioma
- Papillary glioneuronal tumor
- Rosette forming glioneuronal tumor
- Diffuse leptomeningeal glioneuronal tumor
- Central neurocytoma
- Extraventricular neurocytoma
- Cerebellar liponeurocytoma
- ParagangliomaTumor of the Pineal region
- Pineocytoma
- Pineal parenchymal tumor of intermediate differentiation
- Pineoblastoma
- Papillary tumor of pineal regionEmbryonal tumorsMedulloblastoma, genetically definedMedulloblastoma, WNT activatedMedulloblastoma, SHH-activated and T53-mutantMedulloblastoma, SHH-activated and T53-wildtypeMedulloblastoma, non-WNT/non SHHMedulloblastoma, group 3Medulloblastoma, group 4Medulloblastoma, histologically definedMedulloblastoma, classicMedulloblastoma, desmoplastic/nodularMedulloblastoma with extensive nodularityMedulloblastoma, large cell/anaplasticMedulloblastoma NOS
- Embryonal tumor with multilayered rosettes, C19MC-altered
- Embryonal tumor with multilayered rosettes, NOS
- Medulloepithelioma
- CNS Neuroblastoma
- CNS ganglioneuroblastoma
- CNS embryonal tumor, NOS
- Atypical teratoid/ rhabdoid tumor
- CNS embryonal tumor with rhabdoid featuresTumors of cranial and paraspinal nervesSchwannomaCellular SchwannomaPlexiform SchwannomaMelanotic SchwannomaNeurfibromaAtypical neurofibromaPlexiform neurofibromaPerineuriomaHybrid nerve sheath tumorsMalignat peripheral nerve sheath tumorEpitheloid MPNSTMPNST with perineurial differentiationMeningioma
- Meningioma
- Meningothelial meningioma
- Fibrous meningioma
- Transitional meningioma
- Psammomatous meningioma
- Angiomatous meningioma
- Microcystic meningioma
- Secretory meningioma
- Lymphoplasmacyte-rich meningioma
- Metaplastic meningioma
- Chordoid meningioma
- Clear cell meningioma
- Atypical meningioma
- Papillary meningioma
- Rhabdoid meningioma
- Anaplastic ( malignant) meningiomaMesenchymal, Non-meningothelial tumors
- Solitary fibrous tumor/hemangiopericytoma
- Hemangioblastoma
- Hemangioma
- Epitheloid hemangioendothelioma
- Angiosarcoma,
- Kaposi Sarcoma,
- Ewing sarcoma/ PNET
- Lipoma
- Angiolipoma
- Hibernoma
- Liposarcoma
- Desmoid type fibromatosis
- Myofibriblastoma
- Inflammatory myofibroblastic tumor
- Benign fibrous histiocytoma
- Leiomyoma
- Leiomyosarcoma
- Rhabdomyoma
- Rhabdomyosarcoma
- Chondroma’
- Chondrosarcoma
- Osteoma
- Osteochondroam
- OsteosarcomaMelanocytic tumors
- Meningeal melaonocytosis
- Meningeal melanocytoma
- Meningeal melanoma
- Meningeal melanomatosisLymphoma
- Diffuse large B-cell lymphoma of the CNS
- Immunodeficiency-associated CNS lymphomaAIDS-related diffuse large B-cell lymphomaEBV-positive diffuse large B-cell lymphoma, NOSLymphomatoid granulomatosis
- Intravascular large B-cell lymphoma
- Low-grade B-cell lymphoma of the CNS
- T-cell & NK/T cell-lymphoma of the CNS
- Anaplastic large cell lymphoma , ALK-positive
- Anaplastic large cell lymphoma , ALK-negative
- MALT lymphoma of the duraHistiocytic tumors
- Langerhans cell histocytosis
- Erdheim-Chester disease
- Rosai-Dorfman disease
- Juvenile xanthogranuloma
- Histiocytic sarcomaGerm cell tumors
- Germinoma
- Embryonal carcinoma
- Yolk sac tumor
- Choriocarcinoma
- TeratomaMature, Immature
- Teratoma with malignant transformation
- Mixed germ cell tumorTumors of the sellar regionCraniopharyngiomaAdmantinomatous craniopharyngiomaPapillary craniopharyngiomaGranular cell tumor of sellar regionPituicytomaSpindle cell oncocytomaMetastatic tumors
Sources
Review article
The World Health Organization classification of tumors of the central nervous system: a summary. David N. Louis, et al. Acta Neuropathol ( 2016) 131:803-820
If you have Herpes in your whole body such as fever blisters, hsv, or roofing shingles you know what it is like to stay with the pain and discomfort that herpes delivers. I don't need to tell you how awesome it would be to find something that works so well that you no longer need to fear about stress or outbreak,Dr Itua herbal medicine cure my herpes in two weeks of taking it.is genuine and natural herbal medicine it has no side effect, The reason I'm writing this is that I promised Dr Itua I will share his herbal work to the world to see Herpes is no more a big deal.also Dr Itua can as well cure the following diseases...HIV,Hsv 1/2,Hepatitis B,Breast Cancer, Cervical Cancer,Leukuemia Cancer,Lung Cancer,Brain CANCER,Blood Cancer,Prostate Cancer,Diabetes, Men/Woman Infertility, Scoliosis,Fibromyalgia,Fluoroquinolone ToxicitySyndrome Fibrodysplasia Ossificans Progressiva.Fatal Familial Insomnia Facator V Leiden Mutation , Lottery Spell,Copd, Shingles,Fibroid, Fibromyalgia, Liver/Kidney Inflamotry, Epilepsy,Hpv,Weak Erection,Wart Remover,Cold Sore, Coeliac disease,Creutzfeldt–Jakob disease,Cerebral Amyloid Angiopathy, Glaucoma.Lupus, Lymne Disease,, Cataracts,Macular degeneration,Cardiovascular disease,Lung disease.Enlarged prostate,Osteoporosis.Alzheimer's disease,Dementia.Ataxia,Arthritis,Amyotrophic Lateral Sclerosis,Alzheimer's disease,Adrenocortical carcinoma.Asthma,Allergic Asthma. Here His Contact...drituaherbalcenter@gmail.com/ . Whatsapp Phone.+2348149277976. I paid for his herbal medicine and sent it to me through Courier Service which I pick it urgently and used.
ReplyDeletePowerful Herbal treatment is 100% guarantee.
ReplyDeleteHello everyone, I want to say a special thanks to Dr OGU. for helping me get cured from herpes virus 2019 , I contacted him base on the testimonies I saw about him on the internet I was diagnosed of HERPES Virus i have tried all I can to get cured but all to know avail, until i saw a post in a health forum about a herbal man who prepare herbal medication to cure all kind of diseases including HERPES virus, at first i doubted if it was real but decided to give it a try I was cured by his herbal medicine and natural herbs, kindly contact him today through his email: drogugusolutionhome@gmail.com or text/call: +1 (719) 629 0982
He’s waiting to help you.
HE ALSO SPECIALIZE IN THE FOLLOWING DISEASES;
If you have any sickness like : H I V/AIDS , CANCER , HERPES HSV 1 or 2 , GENITAL WARTS, Yeast-infection's (HPV), and Hepatitis A, B. liver diseases , Diabetes, 1 or 2. , fibroids, Chlamydia, Genital herpes, Alzheimer’s, Trichomoniasis , Tuberculosis, CAD, Gonorrhea, Epilepsy, and Syphilis.